Immune function was observed for 144 weeks in 643 human immunodeficiency virus (HIV)–
infected subjects who (1) had nadir CD4+ cell counts of< 50 cells/mm3, followed by a …

Today's antiretroviral combination regimens can induce significant and sustained decreases
in human immunodeficiency virus (HIV)-RNA levels, allowing the immune system to recover …

Background To determine if infectious disease events in HIV‐infected patients treated with
highly active antiretroviral therapy (HAART) are a consequence of the restoration of …

The immunological and virological impact of short-term treatment initiated during acute
human immunodeficiency virus type 1 (HIV-1) infection was assessed prospectively in 20 …

We evaluated phenotypic and functional parameters of immune restoration of 27 HIV-
infected patients on highly active antiretroviral therapy (HAART)(HIV-cases) with HIV-RNA …

The present study investigated immune restoration in patients at intermediate stages of
human immunodeficiency virus (HIV) disease after initiation of highly active antiretroviral …

Abstract Background Suboptimal CD4+ T cell recovery during antiretroviral therapy (ART) is
a common clinical dilemma Methods We analyzed viral and immunologic predictors of CD4+ …

The course of human immunodeficiency virus (HIV) disease is characterized by a
progressive decline in immune function. The advent of highly active antiretroviral therapy …

Background. Descriptions of the durability and consequences of immune reconstitution in
patients who start highly active antiretroviral therapy (HAART) while severely …

Lymphoproliferative responses (LPRs) to recall antigens (Ags) and human
immunodeficiency virus type 1 (HIV-1) Gag and frequencies of circulating HIV-1—specific …